by Commetric | Jul 22, 2022 | Blog
The European Hematology Association’s 2022 Congress saw many pharma companies present their latest work in blood cancer research. Our analysis found that lymphoma became the focus of the media debate around EHA 2022, while companies that reported M&A deals...
by Commetric | Jul 4, 2022 | Blog
The first meeting of the American Society of Clinical Oncology since the start of the pandemic was covered by many pharma publications which followed a wealth of exciting data across the oncology spectrum. Our media analysis found that ASCO gave rise to a new...
![Immunotherapy in the media [Infographic]](https://commetric.com/wp-content/uploads/2022/05/Immunotherapy.jpg)
by Commetric | May 24, 2022 | Blog
Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople,...
by Commetric | May 13, 2022 | Blog
As pharma experiences continued momentum for immuno-oncology treatments, with the current drug development pipeline consisting of thousands of potential therapies and therapy combinations, the media conversation around immuno-oncology is becoming livelier and...
